文献速递主动脉外科

急性A型主动脉夹层全弓置换联合颈动脉置换的结局

Outcomes of Carotid Artery Replacement With Total Arch Reconstruction for Type A Aortic Dissection.
PubMed 文献 · Ann Thorac Surg · 2020-11-27

该回顾性研究纳入2007至2018年因急性A型主动脉夹层行全弓置换的161例患者,其中50例同期行颈动脉置换,111例常规全弓置换。颈动脉置换组术前脑灌注不良和卒中比例更高,但两组30天、1年及5年死亡率以及术后卒中率均无显著差异。结论认为同期颈动脉置换是处理颈动脉夹层相关脑灌注不良的安全可行技术。

要点

  • 同期颈动脉置换组术前脑灌注不良(48% vs 10.81%)和卒中(28% vs 11.71%)比例更高。
  • 两组30天死亡率(22% vs 18.9%)、1年死亡率(28% vs 27.9%)和5年死亡率(32% vs 29.7%)均无显著差异。
  • 术后卒中率颈动脉置换组为0%,常规组为4.5%,差异无统计学意义。

核心结论

  • 同期颈动脉置换是处理急性A型主动脉夹层相关颈动脉夹层及脑灌注不良的安全可行技术。
  • 与常规全弓置换相比,同期颈动脉置换未增加远期死亡率和术后卒中风险。

研究设计与样本

  • 回顾性队列研究,数据来自前瞻性维护数据库,纳入2007至2018年因急性A型主动脉夹层行全弓置换的161例患者。
  • 其中50例同期行颈动脉置换,111例常规全弓置换;采用Kaplan-Meier法评估长期生存,Cox多因素回归分析死亡预测因素。

主要发现

  • 颈动脉置换组术前脑灌注不良发生率48%,常规组10.81%(P < .01)。
  • 颈动脉置换组术前卒中发生率28%,常规组11.71%(P = .02)。
  • 两组30天死亡率分别为22%和18.9%(P = .81),1年死亡率分别为28%和27.9%(P = .99),5年死亡率分别为32%和29.7%(P = .917)。
  • 术后卒中率颈动脉置换组0%,常规组4.5%(P = .301)。

临床怎么用

  • 对于急性A型主动脉夹层合并颈动脉夹层或脑灌注不良的患者,可考虑同期行颈动脉置换。
  • 同期颈动脉置换未显示增加围术期死亡或卒中风险,但需注意该组术前脑灌注不良和卒中比例更高。

局限性

  • 回顾性研究设计,样本量较小(共161例,颈动脉置换组50例),可能存在选择偏倚。
  • 单中心数据,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cerebral malperfusion and carotid artery dissection in patients with acute type A aortic dissections (TAAD) carry high morbidity and mortality. There are limited data on outcomes of concomitant carotid artery replacement with total arch replacement in the setting of TAAD. METHODS: All patients with acute TAAD who underwent a total arch replacement between 2007 and 2018 were included. Data were retrospectively collected from a prospectively maintained database. Baselines variables were compared, and Kaplan-Meier estimates were used for long-term survival. Cox multivariable regression analysis was used to identify predictors of mortality. RESULTS: A total of 161 patients underwent total arch replacement for acute TAAD. Of these, 111 underwent conventional total arch reconstruction, and 50 had a concomitant carotid artery replacement. Baseline characteristics were similar between both cohorts apart from the carotid replacement cohort having a higher rate of preoperative cerebral malperfusion (48% vs 10.81%, P < .01) and preoperative stroke (28% vs 11.71%, P = .02). There was no difference in (operative) 30-day mortality between the carotid replacement and conventional total arch replacement groups (22% vs 18.9%, P = .81), 1-year mortality (28% vs 27.9%, P = .99), or 5-year mortality (32% vs 29.7%, P = .917). Postoperative stroke was 0% vs 4.5% (P = .301) for the carotid vs conventional total arch replacement cohort. CONCLUSIONS: Concomitant carotid artery replacement is a feasible and safe technique to address perioperative cerebral malperfusion, carotid dissection, and neurologic dysfunction associated with carotid artery dissection, with no difference in long-term survival or postoperative stroke when compared with conventional total arch replacement.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Sultan I, Aranda-Michel E, Bianco V, et al. Outcomes of Carotid Artery Replacement With Total Arch Reconstruction for Type A Aortic Dissection. Ann Thorac Surg. 2020. PMID: 33248998. doi:10.1016/j.athoracsur.2020.09.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。